skip to Main Content
Get your free newsletter: Actionable insight each morning for self-directed investors. 

EnWave Corporation (TSX-V:ENW / FSE: E4U) has signed a royalty-bearing commercial license with a fourth Australia based cannabis company called AusCo. The license grants AusCo the right to use EnWave’s patented Radiant Energy Vacuum (REV) technology for the production of cannabis products in Australia.

AusCo has purchased a 10kW REV machine that will be used to dry cannabis flower for use in medicinal products. This REV machine will be built to the standard of Good Manufacturing Practices which will allow AusCo to manufacture EU GMP grade medical cannabis products for export to Europe and other global export markets.

EnWave’s REV technology offers a fast, gentle drying method that removes moisture homogenously from cannabis at selected low temperatures which are below the point of decarboxylation. When compared to incumbent drying methods, REV protocols can be customized to improve terpene retention in the order of 20% or greater and preserve equivalent or higher cannabinoids when compared to conventional rack or room drying methods.

Bioburden (the number of contaminated organisms found in a given amount of material) is also effectively reduced when using select REV protocols. Drying times are shortened from multiple days to less than two hours. REV machinery is manufactured for GACP compliancy and GMP standards upon request – a key manufacturing competency now required by many companies.

REV technology has been proven at scale in the food and cannabis industries. EnWave currently has 49 licensed partners and counting and has installed over 50 royalty-bearing REV machines globally.

Subscribe for more stories like this, 8am weekdays - for free!

Scitek Acquires 10kW REV Machine from Helius

In addition, EnWave’s channel partner representing REV technology in Australasia has agreed to purchase the 10kW non-GMP REV machine from Helius Therapeutics for the purposes of showcasing the technology’s capabilities to a plethora of new potential licensees in both the food and cannabis verticals. Scitek will install their 10kW machine close to Melbourne, and make it available to any interested third-parties for testing and product development.

Concurrently with the transfer of machine ownership to Scitek, Helius and EnWave agreed to terminate their license agreement. Former Helius management purchased a non-GMP REV machine that is not compatible with their full GMP facility classification.

Scitek is a vacuum technology business with over 30 years of industry experience. Their expertise covers a wide range of vacuum facilitating technologies as used in the cannabis, pharmaceutical and food industries. This includes GMP ready solutions for botanical extraction, clean up, concentration and isolation.

REV technology’s commercial viability has been demonstrated and is growing rapidly across several market verticals in the food, and pharmaceutical sectors, including legal cannabis.

EnWave says its strategy is to sign royalty-bearing commercial licenses with innovative, disruptive companies in multiple verticals. The company has signed over forty-five royalty-bearing licenses to date in 20 countries worldwide. In addition to these licenses, EnWave established a Limited Liability Corporation, NutraDried Food Company, to manufacture, market and sell all-natural dairy snack products in the United States, including the Moon Cheese brand.


Please note this article does not constitute investment advice. Investors are encouraged to do their own research beforehand or consult a professional advisor.

Stuart Fieldhouse

Stuart Fieldhouse

Stuart Fieldhouse has spent 25 years in journalism and marketing, including as a wealth management editor for the Financial Times group, covering capital markets and international private banking, and as an investment banking correspondent for Euromoney in Hong Kong. He was the founder editor of The Hedge Fund Journal.

Stuart has worked at CMC Markets, supporting the re-launch of its global financial spread betting and CFD trading platforms. He is also the author of two books on trading, published by Financial Times Pearson. Based in The Armchair Trader’s London office, Stuart continues to advise fund managers, private banks, family offices and other financial institutions.

Stocks in Focus

Here are some of the smaller companies we are following most closely. They all represent significant growth stories in our view. Our in-depth reports go into more detail on why we like them.


Subscribe for more stories like this, 8am weekdays - for free!

Get your free daily newsletter: 

Thanks to our Partners

Our partners are established, regulated businesses and we are grateful for their support.

FP Markets
Back To Top